Resultados globales: 3 registros encontrados en 0.03 segundos.
Artículos, Encontrados 3 registros
Artículos Encontrados 3 registros  
1.
16 p, 1.2 MB Inhibition of Prolyl Oligopeptidase Restores Prohibitin 2 Levels in Psychosis Models : Relationship to Cognitive Deficits in Schizophrenia / Vila, Èlia (Institut de Recerca Sant Joan de Déu) ; Pinacho, Raquel (Institut de Recerca Sant Joan de Déu) ; Prades, Roger (Iproteos S.L.) ; Tarragó, Teresa (Iproteos S.L.) ; Castro Fernánez, Elena (Institut de Salut Carlos III) ; Munarriz-Cuezva, Eva (Institut de Salut Carlos III) ; Meana, J. Javier (Institut de Salut Carlos III) ; Eugui-Anta, Ania (Institut de Recerca Sant Joan de Déu) ; Roldan Molina, Mònica (Hospital Sant Joan de Déu (Manresa)) ; Vera-Montecinos, América (Institut de Recerca Sant Joan de Déu) ; Ramos, Belén (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular)
Cognitive impairment represents one of the core features of schizophrenia. Prolyl Oligopeptidase (POP) inhibition is an emerging strategy for compensating cognitive deficits in hypoglutamatergic states such as schizophrenia, although little is known about how POP inhibitors exert their pharmacological activity. [...]
2023 - 10.3390/ijms24076016
International journal of molecular sciences, Vol. 24 (march 2023)  
2.
14 p, 2.3 MB Analysis of networks in the dorsolateral prefrontal cortex in chronic schizophrenia : Relevance of altered immune response / Vera-Montecinos, América (Institut de Recerca Sant Joan de Déu) ; Rodríguez-Mias, Ricard (University of Washington. Department of Genome Sciences) ; Vila, Èlia (Institut de Recerca Sant Joan de Déu) ; Villén, Judit (University of Washington. Department of Genome Sciences) ; Ramos, Belén (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular)
The dorsolateral prefrontal cortex (DLPFC) has a crucial role in cognitive functioning and negative symptoms in schizophrenia. However, limited information of altered protein networks is available in this region in schizophrenia. [...]
2023 - 10.3389/fphar.2023.1003557
Frontiers in Pharmacology, Vol. 14 (March 2023) , art. 1003557  
3.
15 p, 1.7 MB Kynurenine pathway in post-mortem prefrontal cortex and cerebellum in schizophrenia : relationship with monoamines and symptomatology / Afia, Amira Ben (University of Monastir) ; Vila, Èlia (Institut de Recerca Sant Joan de Déu) ; Macdowell, Karina S (Centro de Investigación Biomédica en Red de Salud Mental) ; Ormazabal, Aida (Institut de Recerca Sant Joan de Déu) ; Leza, Juan Carlos (Centro de Investigación Biomédica en Red de Salud Mental) ; Haro Abad, Josep Maria (Institut de Recerca Sant Joan de Déu) ; Artuch, R. (Institut de Recerca Sant Joan de Déu) ; Ramos, Belén (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Garcia-Bueno, Borja (Centro de Investigación Biomédica en Red de Salud Mental)
The cortico-cerebellar-thalamic-cortical circuit has been implicated in the emergence of psychotic symptoms in schizophrenia (SZ). The kynurenine pathway (KP) has been linked to alterations in glutamatergic and monoaminergic neurotransmission and to SZ symptomatology through the production of the metabolites quinolinic acid (QA) and kynurenic acid (KYNA). [...]
2021 - 10.1186/s12974-021-02260-6
Journal of neuroinflammation, Vol. 18 (September 2021) , art. 198  

¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.